STAGE IIIA BREAST CANCER
Clinical trials for STAGE IIIA BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIIA BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise against aggressive breast cancer
Disease control CompletedThis study tested a combination of two targeted antibodies (pertuzumab and trastuzumab) plus a chemotherapy drug (nab-paclitaxel) in 63 patients with HER2-positive advanced breast cancer. The goal was to see if this triple therapy could shrink tumors or delay the cancer from gett…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 23, 2026 11:54 UTC
-
New hope for tough breast cancer: drug combo shows promise in trial
Disease control CompletedThis study tested a drug called alisertib, either alone or combined with fulvestrant, in 96 postmenopausal women with advanced breast cancer that had stopped responding to hormone therapy. The goal was to see if these treatments could shrink tumors. Alisertib works by blocking en…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 18, 2026 11:49 UTC
-
New drug combo offers hope for elderly breast cancer patients avoiding surgery
Disease control CompletedThis study tested a combination of two drugs, fulvestrant and palbociclib, in older patients with hormone-sensitive breast cancer who either couldn't have surgery or chose not to. The goal was to see if the treatment could control the cancer for at least a year without needing su…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New combo therapy shows promise in preventing breast cancer return
Disease control CompletedThis study looked at whether shutting down the ovaries (ovarian suppression) combined with hormone therapy (tamoxifen or exemestane) could better prevent breast cancer from coming back in premenopausal women with hormone-sensitive breast cancer. Over 3,000 women who had surgery t…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: PHASE3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
Can fish oil and arthritis drugs fight pregnancy breast cancer?
Knowledge-focused CompletedThis study looked at whether two anti-inflammatory drugs—fish oil and celecoxib (an arthritis medication)—can reduce inflammation and slow cancer spread in women with pregnancy-associated breast cancer. 42 women aged 18-50 with various stages of breast cancer took the drugs for a…
Matched conditions: STAGE IIIA BREAST CANCER
Phase: EARLY_PHASE1 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 10, 2026 13:25 UTC